179 related articles for article (PubMed ID: 34471970)
1. Evaluation of an oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization.
Heisler RD; Kelly JJ; Abedinzadegan Abdi S; Hawker JL; Fong LG; Quon JL; Rioux JZ; Jupp JC
Support Care Cancer; 2022 Feb; 30(2):1273-1281. PubMed ID: 34471970
[TBL] [Abstract][Full Text] [Related]
2. Oral Methods of Urinary Alkalinization for High-dose Methotrexate Administration: Alternatives to Intravenous Sodium Bicarbonate During a Critical Drug Shortage.
Visage R; Kaiser N; Williams M; Kim A
J Pediatr Hematol Oncol; 2019 Jul; 41(5):371-375. PubMed ID: 30475303
[TBL] [Abstract][Full Text] [Related]
3. Oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization: A pediatric experience.
Diachinsky M; Tran T; Jupp J; McKinnon K
J Oncol Pharm Pract; 2021 Jan; 27(1):119-127. PubMed ID: 32316877
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of a urine alkalinization protocol developed for high-dose methotrexate patients during intravenous bicarbonate shortage.
Roy AM; Lei M; Lou U
J Oncol Pharm Pract; 2019 Dec; 25(8):1860-1866. PubMed ID: 30636529
[TBL] [Abstract][Full Text] [Related]
5. Assessing the impact of adding acetazolamide to oral or intravenous sodium bicarbonate as compared with intravenous bicarbonate monotherapy as urinary alkalinization in adults receiving high-dose methotrexate.
Clemmons AB; Chase A; Duong P; Waller JL; Saunders K; Bryan L
Support Care Cancer; 2021 Mar; 29(3):1527-1534. PubMed ID: 32725375
[TBL] [Abstract][Full Text] [Related]
6. A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate.
Reed DR; Pierce EJ; Sen JM; Keng MK
Cancer Manag Res; 2019; 11():8065-8072. PubMed ID: 31507329
[TBL] [Abstract][Full Text] [Related]
7. Retrospective evaluation of sodium acetate use for urine alkalinization in patients receiving high dose methotrexate.
Perkey CL; Flynn LA; Lentz K; Butler S
J Oncol Pharm Pract; 2023 Jan; 29(1):119-124. PubMed ID: 34931924
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of methotrexate clearance with an enteral urine alkalinization protocol for patients receiving high-dose methotrexate.
Kramer E; Filtz M; Pace M
J Oncol Pharm Pract; 2021 Jan; 27(1):26-32. PubMed ID: 32164493
[TBL] [Abstract][Full Text] [Related]
9. Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage.
Mangum R; Bernhardt MB; Cheng WS; Schafer ES; Berg SL; Foster JH
Pediatr Blood Cancer; 2020 Sep; 67(9):e28334. PubMed ID: 32608575
[TBL] [Abstract][Full Text] [Related]
10. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.
Drost SA; Wentzell JR; Giguère P; McLurg DL; Sabloff M; Kanji S; Nguyen TT
Pharmacotherapy; 2017 Jun; 37(6):684-691. PubMed ID: 28394433
[TBL] [Abstract][Full Text] [Related]
11. Comparison of enteral and parenteral methods of urine alkalinization in patients receiving high-dose methotrexate.
Rouch JA; Burton B; Dabb A; Brown V; Seung AH; Kinsman K; Holdhoff M
J Oncol Pharm Pract; 2017 Jan; 23(1):3-9. PubMed ID: 26467268
[TBL] [Abstract][Full Text] [Related]
12. Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis.
Kaveh-Ahangaran R; Abdollahi M; Vaezi M; Kasaeian A; Bahlouli Z; Janbabaei G; Mojtahedzadeh A; Mojtahedzadeh M; Djalalinia S; Shahrami B
Daru; 2024 Jun; 32(1):353-377. PubMed ID: 38233724
[TBL] [Abstract][Full Text] [Related]
13. Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate.
Kintzel PE; Campbell AD; Yost KJ; Brinker BT; Arradaza NV; Frobish D; Wehr AM; O'Rourke TJ
J Oncol Pharm Pract; 2012 Jun; 18(2):239-44. PubMed ID: 22075004
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Sodium Bicarbonate and Lactated Ringers Hydration for High-dose Methotrexate Chemotherapy in Children.
Kendrick J; Jacques L; Baadjes B; Carr R
J Pediatr Hematol Oncol; 2022 Nov; 44(8):442-445. PubMed ID: 36301046
[TBL] [Abstract][Full Text] [Related]
15. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
[TBL] [Abstract][Full Text] [Related]
16. Comments on evaluation of an oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization.
Chyu J; Ali Z; Al-Rahawan MM
Support Care Cancer; 2022 Dec; 30(12):9699-9700. PubMed ID: 36258054
[No Abstract] [Full Text] [Related]
17. Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
Mir O; Ropert S; Babinet A; Alexandre J; Larousserie F; Durand JP; Enkaoua E; Anract P; Goldwasser F
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1059-63. PubMed ID: 20155268
[TBL] [Abstract][Full Text] [Related]
18. Ambulatory High-dose Methotrexate Administration in Pediatric Osteosarcoma Patients at a Single Institution in Argentina.
Villegas Rubio JA; Cacciavillano W; Rose A; Zubizarreta P; Scopinaro M
J Pediatr Hematol Oncol; 2017 Oct; 39(7):e349-e352. PubMed ID: 28937522
[TBL] [Abstract][Full Text] [Related]
19. Experience with ambulatory high-dose methotrexate administration as CNS prophylaxis in patients with non-Hodgkin lymphoma.
Pampín R; Labeaga Y; Rodríguez B; Fernández B; Fernández R; Carbajales M
J Oncol Pharm Pract; 2020 Apr; 26(3):549-555. PubMed ID: 31156052
[TBL] [Abstract][Full Text] [Related]
20. Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
Alsdorf WH; Karagiannis P; Langebrake C; Bokemeyer C; Frenzel C
Oncologist; 2021 Feb; 26(2):e327-e332. PubMed ID: 33215763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]